An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

NCT00696436 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1291

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Azilsartan medoxomil
DRUG: Azilsartan medoxomil
DRUG: Valsartan
DRUG: Olmesartan
DRUG: Placebo

Sponsor

Takeda